Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Anti-Hypertensive Drugs - Papua New Guinea

Papua New Guinea
  • The revenue in Papua New Guinea's Anti-Hypertensive Drugs market is anticipated to rise to US$1.14m in 2024.
  • It is expected that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of -0.86%, leading to a market volume of US$1.09m by 2029.
  • When compared globally, United States is projected to generate the highest revenue of US$12.29bn in 2024.
  • Papua New Guinea's anti-hypertensive drug market is witnessing a surge in demand due to the country's high prevalence of hypertension and growing awareness about the importance of managing the condition.

Definition:
Anti-hypertensive drugs are used to treat high blood pressure. This market covers different types of anti-hypertensive drugs, such as calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), beta blockers, and thiazide diuretics.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Johnson & Johnson, AstraZeneca, Boehringer Ingelheim

In-Scope

  • Drugs to treat high blood pressure
  • Pulmonary hypertension

Out-Of-Scope

  • Anti-coagulants
  • Anti-fibrinolytics
  • Cardiology devices
  • Blood pressure meters
Anti-Hypertensive Drugs: market data & analysis - Cover

Market Insights report

Anti-Hypertensive Drugs: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Anti-Hypertensive Drugs market in Papua New Guinea has been steadily growing in recent years.

    Customer preferences:
    As in many other countries, the aging population of Papua New Guinea is driving demand for anti-hypertensive drugs. Additionally, the increasing prevalence of hypertension in the country has led to a greater demand for these medications.

    Trends in the market:
    One trend in the Anti-Hypertensive Drugs market in Papua New Guinea is the increasing availability of generic versions of these medications. This has led to greater affordability and accessibility for patients. Another trend is the growing importance of combination therapies, which allow patients to take multiple medications in one pill.

    Local special circumstances:
    Papua New Guinea is a developing country with limited healthcare infrastructure. This can make it difficult for patients to access the medications they need. Additionally, cultural beliefs and traditional medicine practices can sometimes lead patients to avoid taking Western medications.

    Underlying macroeconomic factors:
    The economy of Papua New Guinea is heavily reliant on natural resources, particularly mining and oil. This can lead to fluctuations in the country's economic growth and can impact the ability of patients to afford medications. Additionally, the country has a high burden of infectious diseases, which can divert resources away from chronic disease management.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Anti-Hypertensive Drugs: market data & analysis - BackgroundAnti-Hypertensive Drugs: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.